Will Allergan Raise It’s Guidance?

[cnbc 3000053555]

David Pyott, Allergan chairman/CEO, discusses the company’s earnings, and products in the big pharma pipeline, with Mad Money’s Jim Cramer.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply